Bruno Wohlschlegel Insider Profile

4 Followers
Bruno Wohlschlegel, Chief Executive Officer at APONTIS PHARMA AG, holds ― shares in APONTIS PHARMA AG (Ticker: DE:APPH). Most recently, Bruno Wohlschlegel Bought €1,000 shares of APONTIS PHARMA AG on May 14, 2024 for an estimated value of 8.88K.
tipranks
Bruno  Wohlschlegel

Bruno Wohlschlegel
APONTIS PHARMA AG (APPH)
Chief Executive Officer

Not Ranked
Bruno Wohlschlegel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Bruno Wohlschlegel does not currently own shares as a corporate insider.
A breakdown of Bruno Wohlschlegel's holdings

Insider Roles

APONTIS PHARMA AG
(APPH)
Chief Executive Officer
Roles that Bruno Wohlschlegel holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Bruno Wohlschlegel

Bruno Wohlschlegel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
APONTIS PHARMA AG
May 14, 2024
Chief Executive Officer
Informative Buy
8.88K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 14, 2024
Informative Buy
€8.88K
-
€8.88
List of latest transactions for each holding click on a transaction to see Bruno Wohlschlegel's performance on stock

Bruno Wohlschlegel insider profile FAQ

What is the percentage of profitable transactions made by Bruno Wohlschlegel?
The percentage of profitable transactions made by Bruno Wohlschlegel is ―.
    What is the average return per transaction made by Bruno Wohlschlegel?
    The average return per transaction made by Bruno Wohlschlegel is ―.
      What stocks does Bruno Wohlschlegel hold?
      Bruno Wohlschlegel holds: DE:APPH stocks.
        What was Bruno Wohlschlegel’s latest transaction?
        Bruno Wohlschlegel latest transaction was an Informative Buy of €8.88K.
          What was Bruno Wohlschlegel's most profitable transaction?
          Bruno Wohlschlegel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Bruno Wohlschlegel's role in APONTIS PHARMA AG?
            Bruno Wohlschlegel's role in APONTIS PHARMA AG is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.